Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Tela Bio Inc. (TELA) Insider Trading Activity
Healthcare • Medical Devices • 227 employees
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Total Value
-$58,164.18
Total Shares
272,056
Average Trade Value
-$2,908.21
Most Active Insider
Koblish Antony
Total Activity: $57,401
Largest Single Transaction
$31,636
by Koblish Antony on Feb 23, 2025
30-Day Activity
4 Transactions
Volume: 789 shares
Value: $963
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Chief Executive Officer
Director, Officer
|
Mar 31, 2025 | 384 | $468 | 590,110 (-0.1%) | Payment of Exercise Price | |
|
Chief Technology Officer
Officer
|
Mar 31, 2025 | 190 | $232 | 123,882 (-0.2%) | Payment of Exercise Price | |
|
Chief Commercial Officer
Officer
|
Mar 31, 2025 | 119 | $145 | 106,804 (-0.1%) | Payment of Exercise Price | |
|
Chief Accounting Officer
Officer
|
Mar 31, 2025 | 96 | $117 | 36,831 (-0.3%) | Payment of Exercise Price | |
|
Chief Accounting Officer
Officer
|
Feb 24, 2025 | 539 | $1,428 | 36,927 (-1.5%) | Payment of Exercise Price | |
|
Chief Executive Officer
Director, Officer
|
Feb 24, 2025 | 5,772 | $15,296 | 590,494 (-1.0%) | Payment of Exercise Price | |
|
Chief Commercial Officer
Officer
|
Feb 24, 2025 | 240 | $636 | 106,923 (-0.2%) | Payment of Exercise Price | |
|
Chief Technology Officer
Officer
|
Feb 24, 2025 | 1,049 | $2,780 | 124,072 (-0.8%) | Payment of Exercise Price | |
|
Chief Executive Officer
Director, Officer
|
Feb 23, 2025 | 11,631 | $31,636 | 596,266 (-2.0%) | Payment of Exercise Price | |
|
COO and CFO
Officer
|
Feb 23, 2025 | 5,234 | $14,236 | 208,233 (-2.5%) | Payment of Exercise Price | |
|
Chief Commercial Officer
Officer
|
Feb 23, 2025 | 1,352 | $3,677 | 107,163 (-1.3%) | Payment of Exercise Price | |
|
Chief Technology Officer
Officer
|
Feb 23, 2025 | 4,061 | $11,046 | 125,121 (-3.2%) | Payment of Exercise Price | |
|
Chief Accounting Officer
Officer
|
Feb 23, 2025 | 423 | $1,151 | 37,466 (-1.1%) | Payment of Exercise Price | |
|
Chief Technology Officer
Officer
|
Feb 21, 2025 | 38,100 | $10,000 | 129,182 (+29.5%) | Grant | |
|
Chief Commercial Officer
Officer
|
Feb 21, 2025 | 51,600 | $10,000 | 108,879 (+47.4%) | Grant | |
|
Chief Commercial Officer
Officer
|
Feb 21, 2025 | 364 | $990 | 108,515 (-0.3%) | Payment of Exercise Price | |
|
Chief Executive Officer
Director, Officer
|
Feb 21, 2025 | 149,000 | $10,000 | 607,897 (+24.5%) | Grant | |
|
Chief Accounting Officer
Officer
|
Feb 21, 2025 | 1,590 | $4,325 | 37,889 (-4.2%) | Payment of Exercise Price | |
|
COO and CFO
Officer
|
Feb 21, 2025 | 57,000 | $0 | 213,467 (+26.7%) | Grant | |
|
Chief Accounting Officer
Officer
|
Feb 19, 2025 | 9,400 | $0 | 39,479 (+23.8%) | Grant |